0.4831

3.90% -0.0196

AEON Biopharma Inc. (AEON)

Overview News Price History Discussions Forecast

AEON Biopharma Inc. stock is traded at $0.4831, with a volume of 65,834. It is down -3.90% in the last 24 hours and down -31.97% over the past month. AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.

Previous Close:

$0.5027

Open:

$0.514

24h Volume:

65,834

Relative Volume:

0.84

Market Cap:

$12.71M

Revenue:

Net Income/Loss:

$-60.11M

P/E Ratio:

-0.1111

EPS:

-4.347

Net Cash Flow:

$-12.04M

1W Performance:

-32.44%

1M Performance:

-31.97%

6M Performance:

-55.27%

1Y Performance:

-43.83%

1-Day Range:

$0.483

$0.5179

1-Week Range:

$0.483

$0.7459

52-Week Range:

$0.483

$1.45

AEON Biopharma Inc. Stock (AEON) Company Profile

Name

AEON Biopharma Inc.

Sector

Healthcare (1096)

Industry

Biotechnology (616)

Phone

(949) 354-6499

Address

5 Park Plaza, Suite 1750, Irvine

Employee

Twitter

Next Earnings Date

2026-08-11

Latest SEC Filings

AEON's Discussions on Twitter

Compare AEON vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AEON AEON Biopharma Inc.	0.4831	12.71M	0	-60.11M	-12.04M	-4.347
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-18-23	Initiated	H.C. Wainwright	Buy

AEON Biopharma Inc. Stock (AEON) Latest News

Jul 09, 2026

AEON Biopharma (NASDAQ: AEON) revises S-1 filing fee table for milestone warrants - Stock Titan

Jul 09, 2026

AEON Biopharma Offering 17.5M Shrs or Pre-Funded Warrants Along With Two-Year and Five-Year Milestone Warrants - Moomoo

Jul 09, 2026

Jul 08, 2026

Form S-1 Aeon Biopharma Inc For: 8 July By Investing.com - Investing.com Nigeria

Jul 08, 2026

AEON Biopharma (AEON) files S-1 for $11M stock sale plus milestone warrants - Stock Titan

Jul 08, 2026

Jul 02, 2026

AEON Q4 2025 Earnings: Wider Loss Misses Estimates Amid Pre-Revenue StageProfit Inflection Point - dars.gov.et

Jul 02, 2026

Jun 30, 2026

Enterprise value to revenue forward of AEON Biopharma, Inc. – AMEX:AEON - TradingView

Jun 28, 2026

Jun 26, 2026

AEON Biopharma, Inc. Class A Actuals & Estimates (AMEX:AEON) - TradingView

Jun 26, 2026

Jun 25, 2026

AEON Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 22, 2026

Form 4 Aeon Biopharma Inc For: 22 June By Investing.com - Investing.com Nigeria

Jun 22, 2026

[Form 4] AEON Biopharma, Inc. Insider Trading Activity - Stock Titan

Jun 22, 2026

AEON Biopharma (AEON) grants 222,684 RSUs to director Palmisano - Stock Titan

Jun 22, 2026

Director at AEON Biopharma (AEON) granted 222,684 RSUs - Stock Titan

Jun 22, 2026

AEON Biopharma (AEON) director awarded 222,684 RSUs in equity grant - Stock Titan

Jun 22, 2026

Director Carter granted 222,684 RSUs at AEON Biopharma (AEON) - Stock Titan

Jun 22, 2026

Jun 21, 2026